Published in N Engl J Med on December 10, 2009
Nandrolone Decanoate in the Treatment of Telomeropathies | NCT02055456
Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med (2012) 6.15
Danazol Treatment for Telomere Diseases. N Engl J Med (2016) 3.39
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood (2013) 2.97
Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths. Nat Protoc (2010) 2.88
TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Cell (2012) 2.74
Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun (2013) 2.56
How I treat acquired aplastic anemia. Blood (2012) 2.44
Aging of blood can be tracked by DNA methylation changes at just three CpG sites. Genome Biol (2014) 2.40
Mediterranean diet and telomere length in Nurses' Health Study: population based cohort study. BMJ (2014) 2.26
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One (2010) 2.19
CTC1 Mutations in a patient with dyskeratosis congenita. Pediatr Blood Cancer (2012) 2.14
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev (2011) 1.98
Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst (2012) 1.82
Telomere length measurement-caveats and a critical assessment of the available technologies and tools. Mutat Res (2011) 1.79
Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet (2012) 1.77
Constitutional telomerase mutations are genetic risk factors for cirrhosis. Hepatology (2011) 1.77
Axis of ageing: telomeres, p53 and mitochondria. Nat Rev Mol Cell Biol (2012) 1.74
Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood (2014) 1.64
Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes. PLoS Genet (2012) 1.57
The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell (2011) 1.55
Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLoS Genet (2011) 1.51
The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol (2013) 1.48
InTERTpreting telomerase structure and function. Nucleic Acids Res (2010) 1.47
Senescence and apoptosis block hematopoietic activation of quiescent hematopoietic stem cells with short telomeres. Blood (2014) 1.46
Genetics of leukocyte telomere length and its role in atherosclerosis. Mutat Res (2011) 1.44
Physical activity, sedentary behavior, and leukocyte telomere length in women. Am J Epidemiol (2012) 1.43
Herpesviruses and chromosomal integration. J Virol (2010) 1.43
Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry (2011) 1.36
A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res (2010) 1.30
Healthy lifestyle and leukocyte telomere length in U.S. women. PLoS One (2012) 1.23
Idiopathic pulmonary fibrosis: update on genetic discoveries. Proc Am Thorac Soc (2011) 1.23
Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia (2011) 1.21
Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis. Dis Model Mech (2013) 1.21
DNA helicase and helicase-nuclease enzymes with a conserved iron-sulfur cluster. Nucleic Acids Res (2012) 1.20
Telomere dysfunction, autoimmunity and aging. Aging Dis (2011) 1.20
Shortened telomeres in individuals with abuse in alcohol consumption. Int J Cancer (2011) 1.19
Tracking and fixed ranking of leukocyte telomere length across the adult life course. Aging Cell (2013) 1.17
Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis. PLoS One (2014) 1.17
Telomerase at the intersection of cancer and aging. Trends Genet (2013) 1.16
Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs. J Clin Invest (2013) 1.13
Telomeres-structure, function, and regulation. Exp Cell Res (2012) 1.11
Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans. PLoS One (2014) 1.11
Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer. Cell Stem Cell (2015) 1.11
Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol (2012) 1.09
Measurement of telomere DNA content by dot blot analysis. Nucleic Acids Res (2011) 1.08
Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis (2013) 1.08
No correlation between childhood maltreatment and telomere length. Biol Psychiatry (2010) 1.07
Natural history of pulmonary fibrosis in two subjects with the same telomerase mutation. Chest (2010) 1.07
The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res (2012) 1.06
High phobic anxiety is related to lower leukocyte telomere length in women. PLoS One (2012) 1.06
Telomerase and telomere-associated proteins: structural insights into mechanism and evolution. Structure (2012) 1.05
Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models. Dis Model Mech (2013) 1.05
Discrimination, racial bias, and telomere length in African-American men. Am J Prev Med (2014) 1.04
Understanding telomere diseases through analysis of patient-derived iPS cells. Curr Opin Genet Dev (2013) 1.03
Long telomeres in peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma. Cancer (2013) 1.03
Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond) (2011) 1.03
Premature aging in telomerase-deficient zebrafish. Dis Model Mech (2013) 1.01
An intricate dance: Life experience, multisystem resiliency, and rate of telomere decline throughout the lifespan. Soc Personal Psychol Compass (2012) 1.01
Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation. Blood (2012) 1.01
Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk. Cancer Epidemiol Biomarkers Prev (2012) 1.00
Cross-sectional Associations between Exposure to Persistent Organic Pollutants and Leukocyte Telomere Length among U.S. Adults in NHANES, 2001-2002. Environ Health Perspect (2015) 1.00
The role of the T cell in age-related inflammation. Age (Dordr) (2012) 1.00
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma. Blood (2013) 0.99
Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita. Blood (2012) 0.99
Viral infection and aging as cofactors for the development of pulmonary fibrosis. Expert Rev Respir Med (2010) 0.99
Telomeres and mitochondria in the aging heart. Circ Res (2012) 0.98
Accelerated aging syndromes, are they relevant to normal human aging? Aging (Albany NY) (2011) 0.97
Low social support is associated with shorter leukocyte telomere length in late life: multi-ethnic study of atherosclerosis. Psychosom Med (2013) 0.97
Telomere fusions in early human breast carcinoma. Proc Natl Acad Sci U S A (2012) 0.97
Red blood cell size is inversely associated with leukocyte telomere length in a large multi-ethnic population. PLoS One (2012) 0.97
Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition. PLoS One (2012) 0.96
Telomere length and long-term endurance exercise: does exercise training affect biological age? A pilot study. PLoS One (2012) 0.95
Telomeres and immune competency. Curr Opin Immunol (2012) 0.94
Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer. Br J Cancer (2013) 0.94
Determinants of telomere attrition over 1 year in healthy older women: stress and health behaviors matter. Mol Psychiatry (2014) 0.93
Telomere dynamics in dyskeratosis congenita: the long and the short of iPS. Cell Res (2011) 0.93
Dyskeratosis congenita and the DNA damage response. Br J Haematol (2011) 0.92
Human telomerase model shows the role of the TEN domain in advancing the double helix for the next polymerization step. Proc Natl Acad Sci U S A (2011) 0.92
Association between leukocyte telomere length and glioma risk: a case-control study. Neuro Oncol (2013) 0.92
Telomere dynamics in mice and humans. Semin Hematol (2013) 0.92
Telomeres, atherosclerosis, and the hemothelium: the longer view. Annu Rev Med (2011) 0.91
Clinical utility gene card for: dyskeratosis congenita. Eur J Hum Genet (2011) 0.91
A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice. Genes Dev (2014) 0.91
Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease. PLoS One (2012) 0.91
The genetic basis of idiopathic pulmonary fibrosis. Eur Respir J (2015) 0.91
Is Post-Traumatic Stress Disorder Associated with Premature Senescence? A Review of the Literature. Am J Geriatr Psychiatry (2015) 0.90
Molecular regulation of telomerase activity in aging. Protein Cell (2011) 0.90
Functional characterization of human CTC1 mutations reveals novel mechanisms responsible for the pathogenesis of the telomere disease Coats plus. Aging Cell (2013) 0.90
Not so benign haematology: anaemia of the elderly. Br J Haematol (2011) 0.90
Genetic variants of 11 telomere-pathway gene loci and the risk of incident type 2 diabetes mellitus: the Women's Genome Health Study. Atherosclerosis (2011) 0.89
Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease. Chest (2015) 0.89
Genetic interstitial lung disease. Clin Chest Med (2011) 0.89
Telomeres, NAFLD and Chronic Liver Disease. Int J Mol Sci (2016) 0.89
Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells. PLoS One (2014) 0.88
Physiology of sedentary behavior and its relationship to health outcomes. Med Sci Sports Exerc (2015) 0.88
Mitochondrial uncoupling protein gene cluster variation (UCP2-UCP3) and the risk of incident type 2 diabetes mellitus: the Women's Genome Health Study. Atherosclerosis (2010) 0.88
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes. Haematologica (2011) 0.88
Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation. Blood (2011) 0.88
Recent insights into inherited bone marrow failure syndromes. Curr Opin Pediatr (2012) 0.88
Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell (1985) 24.17
Creation of human tumour cells with defined genetic elements. Nature (1999) 16.47
Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev (2005) 15.19
Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A (2004) 12.89
A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A (1988) 11.81
Telomere reduction in human colorectal carcinoma and with ageing. Nature (1990) 11.24
Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med (2007) 8.23
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature (2001) 7.95
A telomerase component is defective in the human disease dyskeratosis congenita. Nature (1999) 7.91
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (2000) 7.28
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med (2005) 7.09
Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet (1994) 7.04
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet (2009) 6.91
X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet (1998) 6.82
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet (2007) 6.57
Cloning yeast telomeres on linear plasmid vectors. Cell (1982) 6.39
Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99
Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A (2007) 5.95
Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol (2006) 5.28
White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol (2003) 5.04
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A (2005) 4.64
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet (2004) 4.63
Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med (2006) 4.61
Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A (1994) 4.57
The common biology of cancer and ageing. Nature (2007) 4.28
Cancer in dyskeratosis congenita. Blood (2009) 4.28
The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci U S A (1998) 4.17
Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature (2005) 4.16
New common variants affecting susceptibility to basal cell carcinoma. Nat Genet (2009) 4.15
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet (2008) 4.12
Direct activation of TERT transcription by c-MYC. Nat Genet (1999) 3.98
Dyskeratosis congenita in all its forms. Br J Haematol (2000) 3.89
Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A (2008) 3.86
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
Telomere length, stem cells and aging. Nat Chem Biol (2007) 3.10
Telomeres: cancer to human aging. Annu Rev Cell Dev Biol (2006) 2.88
Telomeres, stem cells, senescence, and cancer. J Clin Invest (2004) 2.87
Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet (1998) 2.87
TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet (2007) 2.84
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet (2003) 2.76
Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood (2003) 2.73
Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis (2001) 2.69
Telomere dysfunction increases mutation rate and genomic instability. Cell (2001) 2.62
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet (2007) 2.61
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 2.44
Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol (1998) 2.43
Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2007) 2.39
Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A (2008) 2.37
Telomere length and the risk of lung cancer. Cancer Sci (2008) 2.35
Human cell senescence as a DNA damage response. Mech Ageing Dev (2005) 2.26
[Principle of marginotomy in template synthesis of polynucleotides]. Dokl Akad Nauk SSSR (1971) 2.26
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet (2008) 2.15
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood (2009) 2.12
Progressive telomere shortening in aplastic anemia. Blood (1998) 2.10
Telomere maintenance and human bone marrow failure. Blood (2008) 2.09
Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet (2002) 2.08
Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene (2002) 1.96
Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol (2008) 1.92
Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood (2001) 1.89
Telomere-related genome instability in cancer. Cold Spring Harb Symp Quant Biol (2005) 1.69
Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis? Leuk Res (2004) 1.67
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proc Natl Acad Sci U S A (2008) 1.65
Leukocyte telomere length and carotid artery intimal medial thickness: the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2008) 1.64
Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency. Blood (2004) 1.60
In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci U S A (1997) 1.58
A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One (2009) 1.57
Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood (1997) 1.52
Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol (1998) 1.47
The relative lengths of individual telomeres are defined in the zygote and strictly maintained during life. Aging Cell (2004) 1.42
Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells (2005) 1.38
Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int J Cancer (2009) 1.33
Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Lung Cancer (2009) 1.31
Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma. J Clin Oncol (2009) 1.29
Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer (2007) 1.27
Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer (2009) 1.22
Hormones and growth factors regulate telomerase activity in ageing and cancer. Mol Cell Endocrinol (2005) 1.16
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer. J Clin Invest (2002) 1.14
Shared environmental factors associated with telomere length maintenance in elderly male twins. Aging Cell (2007) 1.14
Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res (1994) 1.13
Chromosomal instability in Barrett's esophagus is related to telomere shortening. Cancer Epidemiol Biomarkers Prev (2006) 1.12
Dyskeratosis congenita associated with three malignancies. J Eur Acad Dermatol Venereol (2003) 1.06
Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population. Cancer Sci (2009) 1.05
Tumor necrosis factor-alpha inhibits hTERT gene expression in human myeloid normal and leukemic cells. Blood (2005) 1.05
Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. Br J Haematol (1996) 1.01
Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease. Clin Sci (Lond) (2009) 1.00
Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia (1998) 0.97
Older men with higher self-rated socioeconomic status have shorter telomeres. Age Ageing (2009) 0.95
Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes. Genes Chromosomes Cancer (2006) 0.89
Familial idiopathic pulmonary fibrosis in association with bone marrow hypoplasia and hepatic nodular regenerative hyperplasia: a new "trimorphic" syndrome. Thorax (2009) 0.87
A new syndrome of familial aplastic anemia and chronic liver disease. Acta Haematol (1997) 0.87
Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking. Aliment Pharmacol Ther (2005) 0.87
Targeting the telosome: therapeutic implications. Biochim Biophys Acta (2009) 0.86
Deficiency of colonic telomerase in ulcerative colitis. Am J Gastroenterol (2001) 0.86
Nodular regenerative hyperplasia associated to aplastic anemia: a case report and literature review. Ann Hepatol (2006) 0.83
Telomeric associations correlate with telomere length reduction and clonal chromosome aberrations in giant cell tumor of bone. Cytogenet Genome Res (2009) 0.81
Dyskeratosis congenita: delay in diagnosis and successful treatment of pancytopenia by bone marrow transplantation. Br J Dermatol (1992) 0.79
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med (2005) 7.09
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med (2006) 6.90
Hematopoietic-specific microRNA expression in human cells. Leuk Res (2005) 3.95
Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med (2012) 3.93
Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA (2003) 3.90
Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med (2011) 3.82
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med (2015) 3.42
Hybrid DNA virus in Chinese patients with seronegative hepatitis discovered by deep sequencing. Proc Natl Acad Sci U S A (2013) 3.35
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 2.76
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet (2003) 2.76
Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood (2003) 2.73
Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood (2006) 2.69
In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet (2004) 2.47
How I treat acquired aplastic anemia. Blood (2012) 2.44
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 2.44
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 2.36
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood (2009) 2.12
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood (2002) 2.10
Telomere maintenance and human bone marrow failure. Blood (2008) 2.09
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood (2013) 1.97
Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. Blood (2008) 1.95
Th17 immune responses contribute to the pathophysiology of aplastic anemia. Blood (2010) 1.91
Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol (2006) 1.88
Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol (2006) 1.82
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions. J Clin Oncol (2010) 1.79
Constitutional telomerase mutations are genetic risk factors for cirrhosis. Hepatology (2011) 1.77
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica (2009) 1.73
Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood (2004) 1.70
Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol (2006) 1.68
Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na. Leuk Res (2012) 1.65
T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood (2006) 1.64
Mutations in the SBDS gene in acquired aplastic anemia. Blood (2007) 1.62
A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One (2009) 1.57
Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood (2006) 1.57
Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol (2008) 1.49
Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood (2004) 1.46
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood (2007) 1.44
A mouse model of lymphocyte infusion-induced bone marrow failure. Exp Hematol (2004) 1.42
Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detection of hematopoietic stem cell function in normal and Trp53 null mice. Exp Hematol (2008) 1.41
Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients. Exp Hematol (2004) 1.40
Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication. J Virol (2007) 1.40
Myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program (2002) 1.39
The epidemiology of aplastic anemia in Thailand. Blood (2005) 1.38
Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proc Natl Acad Sci U S A (2006) 1.36
Functional characterization of telomerase RNA variants found in patients with hematologic disorders. Blood (2004) 1.33
Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood (2005) 1.30
Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells. J Immunol (2007) 1.28
Hematopoiesis in 3 dimensions: human and murine bone marrow architecture visualized by confocal microscopy. Blood (2010) 1.27
Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica (2010) 1.25
Infections in patients with aplastic anemia. Semin Hematol (2009) 1.25
Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes. Ann Intern Med (2002) 1.25
Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. J Pediatr (2008) 1.22
Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer (2009) 1.22
Granulocyte transfusions in severe aplastic anemia: an eleven-year experience. Haematologica (2009) 1.20
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood (2002) 1.19
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis (2003) 1.18
Nonisotopic detection of microRNA using digoxigenin labeled RNA probes. Mol Cell Probes (2006) 1.18
Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. Clin Infect Dis (2011) 1.16
Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients. Exp Hematol (2008) 1.15
Telomere length is inherited with resetting of the telomere set-point. Proc Natl Acad Sci U S A (2010) 1.15
Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest (2010) 1.14
Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs. J Clin Invest (2013) 1.13
Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis (2003) 1.13
Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure. Blood (2004) 1.12
In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. Blood (2003) 1.12
Marked mitochondrial DNA sequence heterogeneity in single CD34+ cell clones from normal adult bone marrow. Blood (2003) 1.10
T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy. Blood (2010) 1.09
Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine. Haematologica (2010) 1.09
Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Br J Haematol (2004) 1.09
Perforin gene mutations in patients with acquired aplastic anemia. Blood (2007) 1.07
Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers. Blood (2003) 1.06
Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Infect Dis (2003) 1.05
Mitochondrial DNA mutations in patients with myelodysplastic syndromes. Blood (2002) 1.05
Mitochondrial DNA sequence variation in single cells from leukemia patients. Blood (2006) 1.05
External contamination in single cell mtDNA analysis. PLoS One (2007) 1.04
Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia. Blood (2011) 1.04
Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. Cytokine (2012) 1.03
Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia. Exp Hematol (2006) 1.03
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression. Clin Gastroenterol Hepatol (2009) 1.02
Mitochondrial DNA sequence heterogeneity in circulating normal human CD34 cells and granulocytes. Blood (2004) 1.02
Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens. Blood (2002) 1.01
Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation. Blood (2012) 1.01
Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses. J Immunol (2004) 0.98
Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial. Blood (2002) 0.96
Relative incidence of agranulocytosis and aplastic anemia. Am J Hematol (2006) 0.96
A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome. Br J Haematol (2002) 0.96
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology (2008) 0.96
Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia. Blood (2003) 0.96
Age-dependent accumulation of mtDNA mutations in murine hematopoietic stem cells is modulated by the nuclear genetic background. Hum Mol Genet (2006) 0.95
The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failure. Blood (2009) 0.95
Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy? J Clin Oncol (2010) 0.94
Cytogenetic abnormalities in paroxysmal nocturnal haemoglobinuria usually occur in haematopoietic cells that are glycosylphosphatidylinositol-anchored protein (GPI-AP) positive. Br J Haematol (2003) 0.92
Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia. Br J Haematol (2002) 0.92